Single-use consumables market seen reaching $10.2 billion by 2030

The global single-use consumables market is projected to nearly double from 2025 to 2030 as biopharma manufacturing, cell and gene therapies, and contamination-control needs accelerate demand. North America led in 2025, while Asia-Pacific is expected to be the fastest-growing region.

Why it matters: - Single-use consumables are becoming a core input for biopharmaceutical manufacturing, where sterile, disposable systems help reduce contamination risk. - The market’s projected jump to $10.2 billion by 2030 signals continued investment in biologics, mRNA, cell therapies and flexible manufacturing capacity. - The growth also reflects broader pressure on healthcare and life sciences companies to scale production faster and with fewer sanitation risks.

What happened: - The Business Research Company published a report on the global single-use consumables market on Aug. 26, 2026. - The report said the market grew from $4.17 billion in 2025 to $4.96 billion in 2026. - The report projects the market will reach $10.2 billion by 2030, implying a 19.7% compound annual growth rate.

The details: - The report links recent growth to higher biologics manufacturing capacity, more biopharma outsourcing, wider use of disposable systems in cell culture, expansion of contract manufacturing and better access to single-use materials. - The forecast period is supported by demand for mRNA and cell therapies, rapid scale-up requirements, personalized medicine production, closed-system bioprocessing and sustainable disposable materials. - Key trends include broader adoption of single-use bioprocessing technologies, more demand for flexible manufacturing consumables, greater use of pre-sterilized disposable components, growth in modular biomanufacturing facilities and stronger contamination-control focus. - Single-use consumables are one-time-use products used in healthcare and biopharmaceutical production, including monoclonal antibodies, mRNA vaccines and bioconjugates. - The products are designed to support sterile environments and lower contamination risk in sensitive manufacturing and clinical settings. - Sanitation and hygiene are also cited as major market drivers. - UNICEF reported in July 2023 that 3.5 billion people lacked safely managed sanitation in 2022 and 2 billion lacked basic hygiene services. - UNICEF also said universal sanitation coverage by 2030 would require a fivefold increase in safely managed sanitation services and a threefold increase in basic hygiene access.

Between the lines: - The market outlook points to a manufacturing shift toward disposables that can speed setup, simplify scale-up and reduce cleaning burdens. - The emphasis on sustainable disposable materials suggests buyers want environmental improvements without losing the operational advantages of single-use systems. - The sanitation and hygiene backdrop broadens the market story beyond biopharma and reinforces contamination control as a cross-industry need. - North America held the largest market share in 2025, but Asia-Pacific is projected to grow fastest through the forecast period.

What's next: - The market report expects continued expansion through 2030 as biologics, cell therapies and personalized medicine production scale. - The Business Research Company said its 2026 report set includes market attractiveness scoring, TAM analysis, company scoring matrices, forecasting dashboards, hotspot infographics and updated trend graphics. - The company also offered a free sample report and the full market report through its website. - More information is available in the free sample report and the full market report.

The bottom line: - Single-use consumables are moving from niche lab inputs to a growth market tied directly to faster, cleaner and more flexible biomanufacturing.